Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Angela Bischoff"'
Publikováno v:
Molecules, Vol 26, Iss 15, p 4460 (2021)
Neuropeptide Y (NPY) acts via multiple receptor subtypes termed Y1, Y2 and Y5. While Y1 receptor-mediated effects, e.g., in the vasculature, are often sensitive to inhibitors of L-type Ca2+ channels such as nifedipine, little is known about the role
Externí odkaz:
https://doaj.org/article/0f495b1efc5b4964a24047b2a4d10568
Autor:
Tea Kakabadze, Angela Bischoff
Publikováno v:
Frontiers in Pharmacology. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f59d2389bc52dc63858b87c585a32c3f
Autor:
Angela Bischoff, Inga Bodrug
Publikováno v:
Frontiers in Pharmacology. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::346cbd179518b8b5d2405e0d34b8e87e
https://doi.org/10.3389/conf.fphar.2017.62.00019
https://doi.org/10.3389/conf.fphar.2017.62.00019
Publikováno v:
Naunyn-Schmiedeberg s archives of pharmacology, 366(1), 64-68. Springer Verlag
We have compared the effectiveness of problem-based learning (PBL) and classical lecture-based learning (LBL) in conveying medical facts in a general pharmacology class of third year medical students ( n=107). Three groups with a total of 31 students
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7266ee7b280bbca1dd876a272bb167f5
https://doi.org/10.1007/s00210-002-0570-x
https://doi.org/10.1007/s00210-002-0570-x
Autor:
Stefan Herzig, Miriam Saxe, Peter Czyborra, Karl Jakobs, Martin C. Michel, Charlotte Fetscher, Angela Bischoff, Dagmar Meyer zu Heringdorf
Publikováno v:
British Journal of Pharmacology. 135:417-426
We have investigated the vasodilating effects of D-erythro-C2-ceramide (C2-ceramide) in methoxamine-contracted rat mesenteric microvessels. C2-ceramide (10 - 100 microM) caused a concentration-dependent, slowly developing relaxation which reached max
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f33abcb907e4ea92a0fc512897cae74
https://doi.org/10.1038/sj.bjp.0704498
https://doi.org/10.1038/sj.bjp.0704498
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 364:179-182
Sphingosine-1-phosphate (SPP) can constrict isolated intrarenal blood vessels in vitro and reduce renal blood flow in vivo. The present study has investigated the role of extracellular Ca2+ and dihydropyridine-sensitive Ca2+ channels in SPP-induced r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a64336d772d54864ebe58b62171daed8
https://doi.org/10.1007/s002100100446
https://doi.org/10.1007/s002100100446
Publikováno v:
British Journal of Pharmacology. 132:1925-1933
Lysosphingolipids such as sphingosine-1-phosphate (SPP) and sphingosylphosphorylcholine (SPPC) can act on specific G-protein-coupled receptors. Since SPP and SPPC cause renal vasoconstriction, we have investigated their effects on urine and electroly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef32fe30b3532374a94d4a30a9295aa9
https://doi.org/10.1038/sj.bjp.0703969
https://doi.org/10.1038/sj.bjp.0703969
Autor:
Martin C. Michel, Angela Bischoff, Dagmar Meyer zu Heringdorf, Charlotte Fetscher, Karl Jakobs, Peter Czyborra
Publikováno v:
British Journal of Pharmacology. 130:1871-1877
Sphingolipids such as sphingosine-1-phosphate (SPP) and sphingosylphosphorylcholine (SPPC) can act both intracellularly and at G-protein-coupled receptors, some of which were cloned and designated as Edg-receptors. Sphingolipid-induced vascular effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8494441f592e0236afe78e25514280a
https://doi.org/10.1038/sj.bjp.0703515
https://doi.org/10.1038/sj.bjp.0703515
Publikováno v:
British Journal of Pharmacology. 130:1878-1883
Sphingolipids such as sphingosine-1-phosphate (SPP) and sphingosylphosphorylcholine constrict isolated rat intrarenal and mesenteric microvessels in vitro. The present study investigates their effects on the cardiovascular system in vivo in anaesthet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4dc5370243421247171d88549b12ab4
https://doi.org/10.1038/sj.bjp.0703516
https://doi.org/10.1038/sj.bjp.0703516
Autor:
Angela Bischoff, Martin C. Michel
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 78:93-99
Neuropeptide Y (NPY) is an established modulator of renal function. Although NPY reduces renal blood flow and does not alter glomerular filtration rate, it enhances diuresis and natriuresis. Although initial studies on natriuresis did not detect kali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab14f4d6fa90dca7a502ad4cfe4a6518
https://doi.org/10.1139/y99-121
https://doi.org/10.1139/y99-121